Immunotherapy: Antibody drug conjugates from a small molecule perspective

被引：0
|
作者：
Janssen, Maurits [1 ]
Stump, Bernhard [2 ]
机构：
[1] Strategic Business Development, United Kingdom
[2] Development Bioconjugates, United Kingdom
来源：
Manufacturing Chemist | 2021年 / 92卷 / 05期
关键词：
Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Immunotherapies such as ADCs deliver more targeted treatments against cancer that improve the quality of life of the patient compared with traditional chemotherapies. There are many types of cancer therapies, with surgery and radiotherapy often being offered as first choices. These are then followed by chemotherapy to stop or slow down cell growth and, hopefully, prevent the disease from returning after surgery.
引用
收藏
页码：14 / 15
相关论文
共 50 条
  • [31] Design and synthesis of small molecule drug conjugates: Additional structural motifs
    Vlahov, Iontcho
    Zou, Ning
    Felten, Albert
    Leamon, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [32] Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery
    Patel, Tarun Kumar
    Adhikari, Nilanjan
    Amin, Sk Abdul
    Biswas, Swati
    Jha, Tarun
    Ghosh, Balaram
    NEW JOURNAL OF CHEMISTRY, 2021, 45 (12) : 5291 - 5321
  • [33] Trends in small molecule drug properties: A developability molecule assessment perspective
    Agarwal, Prashant
    Huckle, James
    Newman, Jake
    Reid, Darren L.
    DRUG DISCOVERY TODAY, 2022, 27 (12)
  • [34] ANTIBODY TOXIN CONJUGATES - A PERSPECTIVE
    BLAKEY, DC
    WAWRZYNCZAK, EJ
    WALLACE, PM
    THORPE, PE
    PROGRESS IN ALLERGY, 1988, 45 : 50 - 90
  • [35] Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates
    Pillow, Thomas H.
    Sadowsky, Jack D.
    Zhang, Donglu
    Yu, Shang-Fan
    Del Rosario, Geoffrey
    Xu, Keyang
    He, Jintang
    Bhakta, Sunil
    Ohri, Rachana
    Kozak, Katherine R.
    Ha, Edward
    Junutula, Jagath R.
    Flygare, John A.
    CHEMICAL SCIENCE, 2017, 8 (01) : 366 - 370
  • [36] Advancements in small molecule drug design: A structural perspective
    Wu, Ke
    Karapetyan, Eduard
    Schloss, John
    Vadgama, Jaydutt
    Wu, Yong
    DRUG DISCOVERY TODAY, 2023, 28 (10)
  • [37] Antibody-Drug Conjugates, the Combination of Large and Small Therapeutic Molecules
    Kratochvil, B.
    Benesova, E.
    CHEMICKE LISTY, 2023, 117 (05): : 319 - 329
  • [38] Antibody Drug Conjugates for Non-small Cell Lung Cancer
    Hayashi, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S830 - S830
  • [39] ANTIBODY-DRUG CONJUGATES: FROM THE BENCH TO THE CLINIC
    Chari, R. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 20 - 20
  • [40] Management of Toxicities From Antibody-Drug Conjugates
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (02) : 96 - 99
12345